Healthcare provider profile · identity verified

Michael J Osten, MD

Family Practice · SCHAUMBURG, IL · NPI 1124059498

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	904	261
Lisinopril	Lisinopril	560	167
Amlodipine Besylate	Amlodipine Besylate	544	154
Levothyroxine Sodium	Levothyroxine Sodium	490	137
Rosuvastatin Calcium	Rosuvastatin Calcium	488	150
Metformin Hcl	Metformin Hcl	419	119
Losartan Potassium	Losartan Potassium	335	88
Metoprolol Succinate	Metoprolol Succinate	239	60
Hydrochlorothiazide	Hydrochlorothiazide	192	52
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	180	32
Gabapentin	Gabapentin	178	39
Pantoprazole Sodium	Pantoprazole Sodium	173	60
Simvastatin	Simvastatin	172	47
Tamsulosin Hcl	Tamsulosin Hcl	170	51
Metoprolol Tartrate	Metoprolol Tartrate	165	51
Omeprazole	Omeprazole	164	51
Tramadol Hcl	Tramadol Hcl	154	30
Zolpidem Tartrate	Zolpidem Tartrate	139	33
Furosemide	Furosemide	136	37
Fluticasone Propionate	Fluticasone Propionate	127	52
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	127	32
Escitalopram Oxalate	Escitalopram Oxalate	124	31
Alprazolam	Alprazolam	116	27
Allopurinol	Allopurinol	115	32
Famotidine	Famotidine	113	36
Potassium Chloride	Potassium Chloride	109	32
Albuterol Sulfate Hfa	Albuterol Sulfate	106	60
Sertraline Hcl	Sertraline Hcl	104	30
Eliquis	Apixaban	102	19
Montelukast Sodium	Montelukast Sodium	85	23
Meloxicam	Meloxicam	83	35
Finasteride	Finasteride	71	21
Pioglitazone Hcl	Pioglitazone Hcl	69	18
Fluoxetine Hcl	Fluoxetine Hcl	67	21
Trazodone Hcl	Trazodone Hcl	64	15
Lovastatin	Lovastatin	63	11
Atenolol	Atenolol	62	17
Lorazepam	Lorazepam	62	12
Alendronate Sodium	Alendronate Sodium	59	15
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	59	53
Clopidogrel	Clopidogrel Bisulfate	59	16
Januvia	Sitagliptin Phosphate	59	13
Venlafaxine Hcl Er	Venlafaxine Hcl	57	suppressed
Duloxetine Hcl	Duloxetine Hcl	53	12
Amitriptyline Hcl	Amitriptyline Hcl	52	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	51	12
Carvedilol	Carvedilol	49	13
Ezetimibe	Ezetimibe	48	13
Glipizide	Glipizide	48	16
Naproxen	Naproxen	47	20
Ozempic	Semaglutide	46	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	44	13
Bupropion Xl	Bupropion Hcl	43	13
Paroxetine Hcl	Paroxetine Hcl	43	suppressed
Tizanidine Hcl	Tizanidine Hcl	43	27
Azithromycin	Azithromycin	42	36
Metformin Hcl Er	Metformin Hcl	42	16
Enalapril Maleate	Enalapril Maleate	41	11
Synthroid	Levothyroxine Sodium	41	13
Pravastatin Sodium	Pravastatin Sodium	40	12
Prednisone	Prednisone	40	36
Pregabalin	Pregabalin	37	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	35	suppressed
Buspirone Hcl	Buspirone Hcl	34	suppressed
Clonazepam	Clonazepam	34	13
Divalproex Sodium Er	Divalproex Sodium	33	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	32	23
Jardiance	Empagliflozin	31	12
Propranolol Hcl	Propranolol Hcl	30	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	29	25
Warfarin Sodium	Warfarin Sodium	29	suppressed
Xarelto	Rivaroxaban	29	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	28	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	28	suppressed
Glimepiride	Glimepiride	27	suppressed
Celecoxib	Celecoxib	26	suppressed
Donepezil Hcl	Donepezil Hcl	26	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	25	13
Doxycycline Hyclate	Doxycycline Hyclate	24	23
Glipizide Er	Glipizide	23	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	23	suppressed
Nifedipine Er	Nifedipine	23	suppressed
Oxycodone Hcl	Oxycodone Hcl	23	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	23	23
Rybelsus	Semaglutide	23	suppressed
Methylprednisolone	Methylprednisolone	22	20
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	22	suppressed
Valsartan	Valsartan	22	suppressed
Ondansetron Odt	Ondansetron	21	suppressed
Sildenafil Citrate	Sildenafil Citrate	21	suppressed
Farxiga	Dapagliflozin Propanediol	20	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	20	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	19	suppressed
Fenofibrate	Fenofibrate	19	suppressed
Meclizine Hcl	Meclizine Hcl	19	12
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	19	suppressed
Acyclovir	Acyclovir	18	14
Citalopram Hbr	Citalopram Hydrobromide	18	suppressed
Tradjenta	Linagliptin	18	suppressed
Amoxicillin	Amoxicillin	17	13
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	17
Verapamil Er	Verapamil Hcl	17	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Irbesartan	Irbesartan	16	suppressed
Lansoprazole	Lansoprazole	16	suppressed
Levofloxacin	Levofloxacin	16	16
Spironolactone	Spironolactone	16	suppressed
Diazepam	Diazepam	15	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	15	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	15
Wixela Inhub	Fluticasone Propion/Salmeterol	15	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	14	suppressed
Cephalexin	Cephalexin	14	11
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Propranolol Hcl Er	Propranolol Hcl	14	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	13	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Ciclopirox	Ciclopirox	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Klor-Con M20	Potassium Chloride	12	suppressed
Nystatin	Nystatin	12	11
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Trulicity	Dulaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error